Weight loss with liraglutide, a once-daily human glucagon-like peptide-1 analogue for type 2 diabetes treatment as monotherapy or added to metformin, is primarily as a result of a reduction in fat tissue

✍ Scribed by J. Jendle; M. A. Nauck; D. R. Matthews; A. Frid; K. Hermansen; M. Düring; M. Zdravkovic; B. J. Strauss; A. J. Garber; on behalf of the LEAD-2; LEAD-3 Study Groups

• Book ID: 109044915
• Publisher: John Wiley and Sons
• Year: 2009
• Tongue: English
• Weight: 579 KB
• Volume: 11
• Category: Article
• ISSN: 1462-8902
• DOI: 10.1111/j.1463-1326.2009.01158.x